Health IT Analytics February 1, 2018
The All of Us precision medicine research program will increase patient participation, engagement, and data collection to prepare for its national launch.
The All of Us Research Program is in its expanded beta phase and is making strides in patient engagement and data capabilities in preparation for its national launch, according to program director Eric Dishman.
The program, which began its initial beta phase in May of 2017, ultimately aims to collect clinical, lifestyle, and genomic data from at least one million diverse participants over the next few years to advance the development of precision medicine.
“This is a grand experiment of trying to combine a lot of these things that may have been done in pieces in other cohort...
Today's Sponsors
Today's Sponsor